Editas' EDIT-101 Set To Be First In Vivo CRISPR Gene-Editing Therapy In Clinic

DNA
EDIT-101 Aims to treat LCA10 , an inherited childhood blindness • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business